Insulin: what her bills did
What they say
Her campaign describes work across party lines on affordable insulin. In the October 1 debate, James described a reputation for challenging insurers and drug companies that denied care to constituents.
What the record shows ·
In 2019 she and Rep. Andy McKean introduced House File 447 on emergency insulin. The committee widened it to emergency refills of any prescription as House File 700. It passed the House 97-0 with her vote and the Senate, amended, 49-0, but the House never took up the amendment. In 2021 the same refill bill passed the House 91-0 as House File 262, with her vote. She also voted for House File 263, an insulin coverage bill that passed 89-2. Neither got past a Senate subcommittee. In 2023 and 2024 she voted for House File 555, now law, which lets pharmacists refill a prescription without the prescriber's approval under Board of Pharmacy rules. Four more insulin bills she sponsored, from 2020 to 2025, got no further than referral. She also introduced HF 2508 in February 2022 on emergency prescription refills and associated insurance coverage; its history records referral to Commerce.
Limit: The refill access she first sought became law in 2024, in a wider pharmacy bill that does not name insulin. The cost half has no law behind it: none of her insulin coverage bills passed, so the record does not show Iowans getting cheaper insulin from her work. These legislative records document health-access work; they do not independently establish her reputation, every confrontation with an insurer or drug company, or privately reported constituent outcomes.